WuXi XDC Sets IPO Price at Top of End of Range
Wall Street Journal
A unit of Chinese contract drugmaker Wuxi Biologics set its initial public offering price at the top end of its guided range, indicating strong demand in a choppy year for listings in Hong Kong.
https://www.wsj.com/articles/wuxi-xdc-sets-ipo-price-at-top-of-end-of-range-791c4acd